Novian Well being Earns New Product Innovation Award for Novilase Breast Remedy

Novian Well being Earns New Product Innovation Award for Novilase Breast Remedy

Novel laser remedy system may dramatically change the panorama of early-stage breast most cancers therapy

CHICAGO, Dec. 6, 2022 /PRNewswire/ — Novian Well being has obtained Frost & Sullivan’s 2022 European New Product Innovation Award within the breast tumor ablation business for its Novilase® Breast Remedy system. Novilase, a minimally invasive process that makes use of laser ablation to destroy tumors as an alternative choice to surgical procedure, has the potential to make “the therapy of breast most cancers a lot easier and simpler, with considerably decrease negative effects,” in accordance with Frost & Sullivan’s analysis.

“This fast, percutaneous, and ultrasound-guided process wants solely native anesthesia, presents minimal scarring, and ensures decrease ache and fatigue and faster restoration for the sufferers,” stated Debarati Sengupta, Senior Trade Analyst at Frost & Sullivan. “It facilitates a paradigmatic shift within the notion of breast tumor therapy, placing the sufferers’ minds comfy.”

Novilase is a thermal ablation machine that makes use of laser warmth to destroy tumor cells with out lumpectomy surgical procedure. The meant use is for the focal destruction of malignant and benign tumors of the breast as much as 20 mm; for normal surgical procedure procedures together with incision, excision, and ablation of sentimental tissues; and coagulative necrosis and interstitial laser coagulation of sentimental tissues.

It’s the first thermal ablation machine to obtain CE Mark approval within the European Union (EU) and Switzerland for the therapy of each malignant tumors and fibroadenomas (benign breast tumors).

“Laser remedy might help sufferers keep away from the trauma and dangers of breast most cancers surgical procedure,” stated Henry Appelbaum, president and CEO of Novian Well being. “The Novian Well being staff is proud to obtain this award as we start to supply the advantages of this game-changing know-how to breast most cancers sufferers in Europe.”

Novilase is already cleared within the U.S. for the therapy of fibroadenomas, and in 2021 it was granted Breakthrough System designation from the U.S. Meals & Drug Administration for its proposed use in focal destruction of malignant breast tumors. As well as, FDA granted an investigational machine exemption for Novian Well being’s pivotal examine (BR-003), with enrollment anticipated to start out shortly with examine completion by 2024.

How Novilase Works

Yearly, greater than 275,000 girls within the U.S., half 1,000,000 in Europe, and a couple of million worldwide are identified with breast most cancers. About two-thirds of early-stage breast most cancers sufferers and their medical doctors will surgically take away the tumors in a breast-conserving process referred to as a lumpectomy. This leaves a scar and may change the form of a lady’s breast — and as many as 25% of ladies will want extra surgical procedure as a result of their total tumors weren’t eliminated through the preliminary surgical process.

Throughout a Novilase process, medical doctors insert a laser probe instantly into the tumor utilizing ultrasound steerage, just like a breast biopsy. The tumor is then heated by the laser and destroyed. Intra-procedure affirmation of focal destruction is offered by a parallel temperature probe which information temperature on the periphery of the goal ablation zone.

The complete process takes 15 to half-hour and doesn’t require normal anesthesia, in contrast to a lumpectomy. Novilase might be carried out on an outpatient foundation utilizing native anesthesia, with minimal ache and a restoration time of hours as a substitute of days. There’s minimal scarring and no change in breast form. Upon affirmation of focal destruction of the goal malignant tumor by MR imaging, sufferers will proceed with really useful radiation and/or adjuvant therapies.

A number of scientific trials have evaluated Novilase for the therapy of malignant breast tumors. A multi-center trial printed within the Annals of Surgical Oncology in 2018 discovered that, for malignant breast tumors as much as 15 mm, Novilase focally destroyed the tumor in 98% of sufferers.  For tumors as much as 20 mm 91% had been destroyed. As well as, sufferers within the trial reported higher health-related high quality of life outcomes than lumpectomy surgical procedure.

“In addition to the improved high quality of life for the sufferers, this interstitial laser remedy is considerably less expensive than normal breast most cancers surgical procedure, because it eliminates the necessity for hospital stays. The excessive efficacy and considerably decrease possibilities of repeated excision additionally drive adoption,” stated Sengupta.

Concerning the Frost & Sullivan Awards

Frost & Sullivan, a world market intelligence agency, applies a rigorous analytical course of to guage a number of nominees for every award class earlier than figuring out the ultimate award recipient. The method includes an in depth analysis of finest practices standards throughout two dimensions for every nominated Firm.


Based mostly in Chicago, with a subsidiary in Evry, France, Novian Well being Inc. is a privately held medical machine firm with proprietary know-how for focal destruction of tumors utilizing Interstitial Laser Remedy. For extra data, name (312) 266-7200 or entry

Contact: Liz Dowling, (415) 388-2794
Dowling & Dennis PR
[email protected]

SOURCE Novian Well being